iRay Technology Co Ltd
SSE:688301
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
66.9589
124.21
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Operating Margin
iRay Technology Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
|
iRay Technology Co Ltd
SSE:688301
|
20.5B CNY |
28%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
220.6B USD |
18%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
198.8B USD |
29%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
137.8B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
134.5B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
125.3B USD |
19%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
49.3B EUR |
14%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
56.1B USD |
16%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
55.5B USD |
31%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.5B USD |
28%
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
37.5B USD |
14%
|
iRay Technology Co Ltd
Glance View
iRay Technology Co., Ltd., founded in China in 2011, has swiftly emerged as a pivotal player in the realm of X-ray imaging technology. Harnessing a potent blend of innovation and scientific expertise, the company specializes in developing and manufacturing advanced digital X-ray detectors. iRay's cutting-edge detectors are a core component in medical imaging systems, providing clear, high-resolution images that are crucial for accurate diagnostics. As global healthcare standards evolve, the demand for high-quality medical imaging solutions burgeons, positioning iRay as a vital contributor to the modernization of healthcare infrastructure. By capitalizing on technological advancements and the relentless pursuit of precision, iRay ensures its products meet the stringent demands of both domestic and international markets. iRay Technology's business model thrives on its ability to consistently deliver superior-quality imaging solutions while expanding its footprint across diverse sectors. Beyond healthcare, iRay's detectors find applications in industrial non-destructive testing and security inspection, diversifying its revenue streams. The company invests significantly in research and development to maintain its technological edge, aiming to drive innovations that enhance imaging performance and cost-efficiency. This investment in R&D not only fuels product enhancements but also cements iRay’s competitive advantage in a rapidly changing industry. By leveraging a robust sales and distribution network, coupled with strategic partnerships, iRay effectively capitalizes on expanding market opportunities, thereby solidifying its revenue base and ensuring sustainable growth.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on iRay Technology Co Ltd's most recent financial statements, the company has Operating Margin of 27.6%.